487 related items for PubMed ID: 8984515
1. [Limbic-hypothalamic-pituitary-adrenal axis in depression: literature review].
Twardowska K, Rybakowski J.
Psychiatr Pol; 1996; 30(5):741-55. PubMed ID: 8984515
[Abstract] [Full Text] [Related]
2. [Serotoninergic system and limbic-hypothalamic-pituitary-adrenal axis (LHPA axis) in depression].
Cubała WJ, Landowski J.
Psychiatr Pol; 2006; 40(3):415-30. PubMed ID: 17037809
[Abstract] [Full Text] [Related]
3. The hypothalamic-pituitary-adrenal axis in depression.
Meltzer HY, Lowy MT, Koenig JI.
Adv Biochem Psychopharmacol; 1987; 43():165-82. PubMed ID: 3035885
[No Abstract] [Full Text] [Related]
4. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
[Abstract] [Full Text] [Related]
5. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
Psychoneuroendocrinology; 2004 Oct; 29(9):1101-8. PubMed ID: 15219633
[Abstract] [Full Text] [Related]
6. Pituitary-adrenal cortical axis measures as predictors of sustained remission in major depression.
O'Toole SM, Sekula LK, Rubin RT.
Biol Psychiatry; 1997 Jul 15; 42(2):85-9. PubMed ID: 9209724
[Abstract] [Full Text] [Related]
7. Limbic and HPA axis function in an animal model of chronic neuropathic pain.
Ulrich-Lai YM, Xie W, Meij JT, Dolgas CM, Yu L, Herman JP.
Physiol Behav; 2006 Jun 15; 88(1-2):67-76. PubMed ID: 16647726
[Abstract] [Full Text] [Related]
8. The neurobiological basis of mixed depression-anxiety states.
Gulley LR, Nemeroff CB.
J Clin Psychiatry; 1993 Jan 15; 54 Suppl():16-9. PubMed ID: 8093884
[Abstract] [Full Text] [Related]
9. Depression and endocrine disorders: focus on the thyroid and adrenal system.
Musselman DL, Nemeroff CB.
Br J Psychiatry Suppl; 1996 Jun 15; (30):123-8. PubMed ID: 8864158
[Abstract] [Full Text] [Related]
10. Involvement and role of antidepressant drugs of the hypothalamic-pituitary-adrenal axis and glucocorticoid receptor function.
Nikisch G.
Neuro Endocrinol Lett; 2009 Mar 15; 30(1):11-6. PubMed ID: 19300389
[Abstract] [Full Text] [Related]
11. Effect of antidepressant drugs on the hypothalamic-pituitary-adrenal axis activity and glucocorticoid receptor function.
Budziszewska B.
Pol J Pharmacol; 2002 Mar 15; 54(4):343-9. PubMed ID: 12523487
[Abstract] [Full Text] [Related]
12. Hypercortisolemia and depression.
Gillespie CF, Nemeroff CB.
Psychosom Med; 2005 Mar 15; 67 Suppl 1():S26-8. PubMed ID: 15953796
[Abstract] [Full Text] [Related]
13. Glucocorticoid receptors in depression.
Pariante CM, Nemeroff CB, Miller AH.
Isr J Med Sci; 1995 Dec 15; 31(12):705-12. PubMed ID: 8543464
[Abstract] [Full Text] [Related]
14. HPA axis dysfunction in unmedicated major depressive disorder and its normalization by pharmacotherapy correlates with alteration of neural activity in prefrontal cortex and limbic/paralimbic regions.
Aihara M, Ida I, Yuuki N, Oshima A, Kumano H, Takahashi K, Fukuda M, Oriuchi N, Endo K, Matsuda H, Mikuni M.
Psychiatry Res; 2007 Aug 15; 155(3):245-56. PubMed ID: 17587554
[Abstract] [Full Text] [Related]
15. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
Bschor T, Lewitzka U, Sasse J, Adli M, Köberle U, Bauer M.
Pharmacopsychiatry; 2003 Nov 15; 36 Suppl 3():S230-4. PubMed ID: 14677084
[Abstract] [Full Text] [Related]
16. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial.
Künzel HE, Ackl N, Hatzinger M, Held K, Holsboer-Trachsler E, Ising M, Kaschka W, Kasper S, Konstantinidis A, Sonntag A, Uhr M, Yassouridis A, Holsboer F, Steiger A.
J Psychiatr Res; 2009 Apr 15; 43(7):702-10. PubMed ID: 19038406
[Abstract] [Full Text] [Related]
17. Changes in the hypothalamic-pituitary-adrenal axis and leptin levels during antidepressant treatment.
Himmerich H, Zimmermann P, Ising M, Kloiber S, Lucae S, Kunzel HE, Binder EB, Holsboer F, Uhr M.
Neuropsychobiology; 2007 Apr 15; 55(1):28-35. PubMed ID: 17556850
[Abstract] [Full Text] [Related]
18. Hypothalamic-pituitary-adrenal axis activity and age in major depression.
Nelson WH, Orr WW, Shane SR, Stevenson JM.
J Clin Psychiatry; 1984 Mar 15; 45(3):120-1. PubMed ID: 6698943
[Abstract] [Full Text] [Related]
19. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: the role of CRH and AVP.
Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC.
J Psychiatr Res; 2007 Mar 15; 41(1-2):131-43. PubMed ID: 16455105
[Abstract] [Full Text] [Related]
20. Cognitive dysfunction, hippocampal atrophy and glucocorticoid feedback in Alzheimer's disease.
Elgh E, Lindqvist Astot A, Fagerlund M, Eriksson S, Olsson T, Näsman B.
Biol Psychiatry; 2006 Jan 15; 59(2):155-61. PubMed ID: 16125145
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
